Benjamin Winograd is the founder of Lava Therapeutics. Lava Therapeutics has raised $83M in total funding. Latest round: Series C.
Benjamin Winograd is a seasoned drug development expert with over 35 years of experience in the pharmaceutical industry. He has a significant background in leading oncology and hematology programs, including major contributions to the registration of lenalidomide and pomalidamide.
Full founder directory · Investor directory · Company funding database · Fundraising library